Opal

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameOpal
Drug Alias NameOpal
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor ligand superfamily member 9 Gene transferenceProgrammed cell death protein 1 blockers
TargetsTumor necrosis factor ligand superfamily member 9Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCullinan Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCullinan Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A